168 related articles for article (PubMed ID: 38573644)
1. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
[TBL] [Abstract][Full Text] [Related]
2. Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.
Chera BS; Kumar S; Shen C; Amdur R; Dagan R; Green R; Goldman E; Weiss J; Grilley-Olson J; Patel S; Zanation A; Hackman T; Blumberg J; Patel S; Thorp B; Weissler M; Yarbrough W; Sheets N; Mendenhall W; Tan XM; Gupta GP
J Clin Oncol; 2020 Apr; 38(10):1050-1058. PubMed ID: 32017652
[TBL] [Abstract][Full Text] [Related]
3. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
[TBL] [Abstract][Full Text] [Related]
4. Association of Pretreatment Circulating Tumor Tissue-Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal Cancer.
Rettig EM; Wang AA; Tran NA; Carey E; Dey T; Schoenfeld JD; Sehgal K; Guenette JP; Margalit DN; Sethi R; Uppaluri R; Tishler RB; Annino DJ; Goguen LA; Jo VY; Haddad RI; Hanna GJ
JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1120-1130. PubMed ID: 36301568
[TBL] [Abstract][Full Text] [Related]
5. Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer.
Chera BS; Kumar S; Beaty BT; Marron D; Jefferys S; Green R; Goldman EC; Amdur R; Sheets N; Dagan R; Hayes DN; Weiss J; Grilley-Olson JE; Zanation A; Hackman T; Blumberg JM; Patel S; Weissler M; Tan XM; Parker JS; Mendenhall W; Gupta GP
Clin Cancer Res; 2019 Aug; 25(15):4682-4690. PubMed ID: 31088830
[TBL] [Abstract][Full Text] [Related]
6. Association of Core Biopsy With Extranodal Extension in Surgically Treated Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Zhu VL; Rand DR; Arnold KE; Pagedar NA; Bayon R; Buchakjian MR
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):955-960. PubMed ID: 37433026
[TBL] [Abstract][Full Text] [Related]
7. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.
Zebolsky AL; George E; Gulati A; Wai KC; Carpenter P; Van Zante A; Ha PK; Heaton CM; Ryan WR
JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1080-1088. PubMed ID: 34673904
[TBL] [Abstract][Full Text] [Related]
8. Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Routman DM; Kumar S; Chera BS; Jethwa KR; Van Abel KM; Frechette K; DeWees T; Golafshar M; Garcia JJ; Price DL; Kasperbauer JL; Patel SH; Neben-Wittich MA; Laack NL; Chintakuntlawar AV; Price KA; Liu MC; Foote RL; Moore EJ; Gupta GP; Ma DJ
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):530-538. PubMed ID: 35157995
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus circulating tumor DNA: a diagnostic tool in squamous cell carcinoma of unknown primary-a pilot study.
Kais A; Santiago SP; Han PC; Clump DA; Stokes WA; Fancy T; Cui R; Martin E; Turner MT
Front Oncol; 2024; 14():1376595. PubMed ID: 38628671
[TBL] [Abstract][Full Text] [Related]
10. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
11. Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer.
Ferrandino RM; Chen S; Kappauf C; Barlow J; Gold BS; Berger MH; Westra WH; Teng MS; Khan MN; Posner MR; Misiukiewicz KJ; Bakst RL; Sindhu KK; Genden EM; Chai RL; Roof SA
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):971-977. PubMed ID: 37422913
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor-tissue modified HPV DNA testing in the clinical evaluation of patients at risk for HPV-positive oropharynx cancer: The IDEA-HPV study.
Batool S; Sethi RKV; Wang A; Dabekaussen K; Egloff AM; Del Vecchio Fitz C; Kuperwasser C; Uppaluri R; Shin J; Rettig EM
Oral Oncol; 2023 Dec; 147():106584. PubMed ID: 37837735
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor HPV DNA assessments after surgery for human papilloma virus-associated oropharynx carcinoma.
Souza SS; Stephens EM; Bourdillon AT; Bhethanabotla R; Farzal Z; Plonowska-Hirschfeld K; Qualliotine JR; Heaton CM; Ha PK; Ryan WR
Am J Otolaryngol; 2024; 45(2):104184. PubMed ID: 38101135
[TBL] [Abstract][Full Text] [Related]
14. It is time to improve the diagnostic workup of oropharyngeal cancer with circulating tumor HPV DNA: Systematic review and meta-analysis.
Paolini F; Campo F; Iocca O; Manciocco V; De Virgilio A; De Pascale V; Moretto S; Dalfino G; Vidiri A; Blandino G; Pimpinelli F; Venuti A; Pellini R
Head Neck; 2023 Nov; 45(11):2945-2954. PubMed ID: 37715656
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
16. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.
Kornfeld B; Taha A; Kyang L; Sim HW; Dewhurst S; McCloy R; Chin V; Earls P; Parker A; Leavers B; Forstner D; Floros P; Crawford J; Gallagher R
J Robot Surg; 2024 May; 18(1):226. PubMed ID: 38806847
[TBL] [Abstract][Full Text] [Related]
17. PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal Cancer.
Snyder V; Goyal LK; Bowers EMR; Kubik M; Kim S; Ferris RL; Johnson JT; Duvvuri U; Gooding WE; Branstetter BF; Rath TJ; Sridharan SS
Laryngoscope; 2021 Jul; 131(7):1535-1541. PubMed ID: 33428218
[TBL] [Abstract][Full Text] [Related]
18. From planned neck dissection to PET response to circulating tumour DNA: changes in post-treatment assessment of HPV-driven oropharyngeal cancer
Post CM; Ohaegbulam KC; Mitin T
J Med Radiat Sci; 2024 Mar; 71(1):21-25. PubMed ID: 37715340
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery.
Roden DF; Hobelmann K; Vimawala S; Richa T; Fundakowski CE; Goldman R; Luginbuhl A; Curry JM; Cognetti DM
Cancer; 2020 Jan; 126(9):1873-1887. PubMed ID: 32032441
[TBL] [Abstract][Full Text] [Related]
20. Double trouble: Synchronous and metachronous primaries confound ctHPVDNA monitoring.
Naegele S; Efthymiou V; Hirayama S; Zhao BY; Das D; Chan AW; Richmon JD; Iafrate AJ; Faden DL
Head Neck; 2023 Jun; 45(6):E25-E30. PubMed ID: 37080924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
